Business Context and Reporting Period
Company: Immunocore Holdings Plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three months ended March 31, 2021
Filing Date: May 12, 2021
This filing incorporates by reference the Unaudited Condensed Consolidated Interim Financial Statements and Management's Discussion and Analysis (MD&A) for the quarter ended March 31, 2021. The registrant is a foreign private issuer filing under Form 20-F.
Key Financial Metrics
The provided text serves as a cover sheet and index for the Form 6-K. It references Exhibits 99.1 and 99.2 containing the financial data but does not explicitly state the numerical values within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Note: Specific financial figures are located in the referenced exhibits (99.1 and 99.2) which are not included in the input content.
Material Changes
The filing text does not contain specific data regarding material changes in financial position or results of operations compared to the prior comparable period. Such analysis is contained within the incorporated Exhibit 99.2 (MD&A).
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes a cautionary note regarding forward-looking statements. These statements involve risks and uncertainties, and actual results may differ materially from expectations. The company undertakes no obligation to update these statements except as required by law.
Risk Factors: Investors are directed to the "Risk Factors" sections in the company's other SEC filings for a discussion of factors that may cause actual results to differ from forward-looking statements.
Exhibits: Exhibit 99.3 is a press release dated May 12, 2021, which is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific revenue, net loss, and cash burn figures in Exhibit 99.1 (Unaudited Condensed Consolidated Interim Financial Statements).
- Review Exhibit 99.2 (MD&A) for management's explanation of operational results and liquidity position.
- Read Exhibit 99.3 (Press Release) for any material announcements made on May 12, 2021.
- Consult the most recent Form 20-F for detailed risk factors and long-term strategic outlook.